Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

CVS Health Credit Ratings And Price Target Update By Various Research Firms

|Includes: CVS Health Corporation (CVS)

Morningstar research firm updated the credit rating of the company to BBB+ and 2 star rating.

CVS Health Corp has got a credit rating of BBB+ along with a 2 star rating from Morningstar research analysts. The research company's rating of BBB+ means that the health company is at moderate risk.

A number of research analysts have noted the movement of the stock and have commented on CVS Health. On March 12th Thursday, analysts at Zacks recapped its previous neutral rating to the share of the company and assigned a fresh $107 target price. Deutsche Bank research analysts surged their target price to the stock by almost $9 to $109 from previous $100 and a hold rating was suggested by them on Friday 13th February research note. Citigroup Inc. analysts also retold their Hold rating and assigned $110 target price up by $8 dollar from previous $102 on the similar day research note. In the end, Standard and Poors equity research analysts' demoted stock of the health care company to a rating of hold on February 11th Wednesday research note. Two of the research analysts have given a short rating, while five have recommended a rating of Hold with fifteen Long rating to the share of the American retailer company. Currently, the average rating to the stock is Buy and $98.20 of target price.

CVS Health Corp started trading at $103.49 on Thursday morning; the company has a 52 week high and low of $104.84 and $72.37. The 50 day and 200 day moving average is $102 and $91 respectively. The Health care firm has a $117.98 of market capitalization and 26.14 times of price earnings ratio.

The earnings report for October to December 2014 quarter was reported on February 10th Tuesday by the company. The results showed earnings of $1.21 per share for the fourth quarter thrashing analysts' consent of $1.20 by exact 1 cent. It also had $37.06 of revenue for the period slightly more than analysts forecast of $36.06 billion. In the similar period the prior year, company was able to post earnings of $1.12 per share. Its year over year revenue has gone up by 12.9% in contrast with the last year 4th quarter. On the whole; there are predictions by researchers that the Health care Company will be able to post $5.16 EPS for the fiscal year 2015.

Quarterly dividend has been lately announced by the pharmaceutical company that will be paid on 4th May Monday. Of record shareholders on April 24th will get a dividend of 35 cents against each share they own. This signifies an annual dividend of $1.40 and 1.35% of dividend yield.

CVS Stock went red by 0.14% to $103.14 on Thursday.